NPPA caps trade margins on 137 non-scheduled anti-cancer drugs at 30 per cent

Sun, 18 Oct 2026 09:06:18 +0530

The National Pharmaceutical Pricing Authority (NPPA) has capped trade margins at 30 per cent of the maximum retail price (MRP) on 137 non-scheduled anti-cancer drugs, according to a notification reported by The Indian Express and The Tribune on Saturday, 17 October 2026. The revised prices will come into effect on 9 November 2026. The NPPA’s own notification could not be accessed for this report; the details below are as reported by those outlets.

Drug Pricing on Indian Politics

NPPA caps trade margins on 137 non-scheduled anti-cancer drugs at 30 per cent